Patents by Inventor Thomas S. ULDRICK

Thomas S. ULDRICK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for the treatment of Kaposi's sarcoma or KSHV-induced lymphoma using immunomodulatory compounds, and uses of biomarkers
    Patent number: 10001483
    Abstract: Provided herein are uses of gene and protein biomarkers as a predictor of clinical sensitivity of Kaposi's sarcoma (KS) or Kaposi's sarcoma-associated herpesvirus (KSHV) induced lymphoma and patient response to treatment with an immunomodulatory compound. Further provided herein are methods for the treatment or management of Kaposi's sarcoma or KSHV-induced lymphoma with an immunomodulatory compound, alone or in combination with doxorubicin.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: June 19, 2018
    Assignees: Celgene Corporation, The United States of America, as Represented by the Secretary, Department of Health and Human Services
    Inventors: Robert Yarchoan, Jerome B. Zeldis, Mark N. Polizzotto, David A. Davis, Irini Sereti, Thomas S. Uldrick, Denise Whitby, Vikram Khetani
  • METHODS FOR THE TREATMENT OF KAPOSI'S SARCOMA OR KSHV-INDUCED LYMPHOMA USING IMMUNOMODULATORY COMPOUNDS, AND USES OF BIOMARKERS
    Publication number: 20160377621
    Abstract: Provided herein are uses of gene and protein biomarkers as a predictor of clinical sensitivity of Kaposi's sarcoma (KS) or Kaposi's sarcoma-associated herpesvirus (KSHV) induced lymphoma and patient response to treatment with an immunomodulatory compound. Further provided herein are methods for the treatment or management of Kaposi's sarcoma or KSHV-induced lymphoma with an immunomodulatory compound, alone or in combination with doxorubicin.
    Type: Application
    Filed: June 24, 2016
    Publication date: December 29, 2016
    Inventors: Robert YARCHOAN, Jerome B. ZELDIS, Mark N. POLIZZOTTO, David A. DAVIS, Irini SERETI, Thomas S. ULDRICK, Denise WHITBY, Vikram KHETANI